UA41734U - Method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, which are under the influence of alcoholic intoxication - Google Patents

Method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, which are under the influence of alcoholic intoxication

Info

Publication number
UA41734U
UA41734U UAU200813405U UAU200813405U UA41734U UA 41734 U UA41734 U UA 41734U UA U200813405 U UAU200813405 U UA U200813405U UA U200813405 U UAU200813405 U UA U200813405U UA 41734 U UA41734 U UA 41734U
Authority
UA
Ukraine
Prior art keywords
insufficiency
women
correction
influence
under
Prior art date
Application number
UAU200813405U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Василий Васильевич Подольский
Виктория Леонидовна Дронова
Людмила Анатолиевна Охрименко
Зинаида Борисовна Хоминская
Владимир Васильевич Подольский
Original Assignee
Институт Педиатрии, Акушерства И Гинекологии Академии Медицинских Наук Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Педиатрии, Акушерства И Гинекологии Академии Медицинских Наук Украины filed Critical Институт Педиатрии, Акушерства И Гинекологии Академии Медицинских Наук Украины
Priority to UAU200813405U priority Critical patent/UA41734U/en
Publication of UA41734U publication Critical patent/UA41734U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, being under the influence of alcoholic intoxication, is carried out using the basic therapy. The "Ovarium-kompozitum" antihomotoxic preparation and "Yantarin-detoks" biologically active additive are prescribed in therapeutic doses.
UAU200813405U 2008-11-20 2008-11-20 Method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, which are under the influence of alcoholic intoxication UA41734U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200813405U UA41734U (en) 2008-11-20 2008-11-20 Method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, which are under the influence of alcoholic intoxication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200813405U UA41734U (en) 2008-11-20 2008-11-20 Method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, which are under the influence of alcoholic intoxication

Publications (1)

Publication Number Publication Date
UA41734U true UA41734U (en) 2009-06-10

Family

ID=50631723

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200813405U UA41734U (en) 2008-11-20 2008-11-20 Method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, which are under the influence of alcoholic intoxication

Country Status (1)

Country Link
UA (1) UA41734U (en)

Similar Documents

Publication Publication Date Title
MY148637A (en) Anti-glypican-3 antibody having improved kinetics in plasma
NZ717373A (en) The use of inhibitors of bruton’s tyrosine kinase (btk)
MY149731A (en) Compounds
MX2009002314A (en) Pharmaceutical compositions comprising hgh for oral delivery.
NZ598524A (en) Therapeutic dll4 binding proteins
WO2011107653A8 (en) Use of levodopa, carbidopa and entacapone for treating parkinson's disease
NZ598722A (en) Methods for treating psoriasis
IN2012DN03172A (en)
MX338088B (en) 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes.
UA105644C2 (en) Methods of treating pulmonary disorders with liposomal amikacin formulations
MY168763A (en) Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
NZ597030A (en) Method for treatment of diseases
HK1216007A1 (en) Fusion of human growth hormone and albumin, formulation and uses thereof
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
TW200612922A (en) Inhibitors of hsp90
MX2010006724A (en) Therapeutic regimens for the treatment of immunoinflammatory disorders.
UA41734U (en) Method for correction of insufficiency of menstrual cycle luteal phase in the reproductive age-women, which are under the influence of alcoholic intoxication
MX2008015323A (en) Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association.
SG179056A1 (en) [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
MX2012005497A (en) Tivozanib and temsirolimus in combination.
TN2013000336A1 (en) 5s,8s)-3-(4'-chlor-3'-fluoro-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for therapy.
UA33293U (en) Method for treating chronic endometritis
UA40736U (en) METHOD FOR TREATMENT OF VERTEBROGENIUOS radiculopathy
RU2008130241A (en) METHOD AND MEANS FOR REHABILITATION OF CHILDREN WITH CHRONIC RHINOSINUSITES
TNSN06305A1 (en) Treatment regimen for camptothecin derivatives